Royal Bank of Canada
DSCI

Royal Bank of Canada’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Royal Bank of Canada’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-65
Closed – – 7266
2015
Q3 		$0 Buy
+65
New +$420 ﹤0.01% 7093
2015
Q2 		– Sell
-69
Closed -$1K – 6978
2015
Q1 		$1K Buy
+69
New +$588 ﹤0.01% 6080
2014
Q4 		– Sell
-800
Closed -$7K – 6637
2014
Q3 		$7K Buy
800
+777
+3,378% +$7.2K ﹤0.01% 5598
2014
Q2 		$0 Buy
+23
New +$236 ﹤0.01% 6504
2013
Q4 		– Sell
-503
Closed -$6K – 6608
2013
Q3 		$6K Buy
+503
New +$6.96K ﹤0.01% 5616

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Royal Bank of Canada's DSCI Position: Q4 2015 in Review

Royal Bank of Canada sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2015, closing a stake of 65 shares.

Royal Bank of Canada first reported a position in DSCI in Q3 2013 and held it in 5 quarters. The position peaked at $7K in Q3 2014. 59 funds tracked by Wall St. Rank hold DSCI as of Q4 2015.

  • Royal Bank of Canada reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 65 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2015.
  • Royal Bank of Canada first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q3 2013 and held it in 5 quarters.
  • Royal Bank of Canada's Derma Sciences, Inc. Common Stock (DE) position peaked at $7K in Q3 2014.
  • 59 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2015.

Based on Royal Bank of Canada's 13F filing for Q4 2015, filed 16 Feb 2016.